HomecollectionsProfessor Product PortalEllman Group – Professor Product Portal

Ellman Group – Professor Product Portal

Jonathan Ellman

Professor Jonathan A. Ellman

The Ellman group has participated in the development of a variety of C-H functionalization methods. An electron rich phosphine ligand has proven to be very useful for a variety of Rh(I)-catalyzed C-C bond forming reactions applicable to heterocycle synthesis as exemplified in the recent Science paper “Proton Donor Acidity Controls Selectivity in Nonaromatic Nitrogen Heterocycle Synthesis.” Another useful ligand developed for the highly functional group compatible direct arylation of nitrogen heterocycles is described in a 2008 J. Am. Chem. Soc. paper “Rh(I)-Catalyzed Arylation of Heterocycles via C-H Bond Activation: Expanded Scope through Mechanistic Insight.”

The Ellman group also developed the chiral amine reagent tert-Butanesulfinamide, which is extensively used in academics and industry for the asymmetric synthesis of amines. A comprehensive survey of tert-Butanesulfinamide methods and applications up through 2009 is provided in the 2010 Chemical Reviews article, “Synthesis and Applications of tert-Butanesulfinamide.”

Ellman Group Website

Recent papers from the Ellman Group

Duttwyler S, Chen S, Takase MK, Wiberg KB, Bergman RG, Ellman JA. 2013. Proton Donor Acidity Controls Selectivity in Nonaromatic Nitrogen Heterocycle Synthesis. Science. 339(6120):678-682. http://dx.doi.org/10.1126/science.1230704
Robak MT, Herbage MA, Ellman JA. 2010. Synthesis and Applications of tert-Butanesulfinamide. Chem. Rev.. 110(6):3600-3740. http://dx.doi.org/10.1021/cr900382t
Products available from the Ellman Group:


  • Organic Synthetic Chemistry

Professor Product Portal Index

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.